Diplomat Pharmacy Inc. has closed its $595 million acquisition of pharmacy benefit manager LDI Integrated Pharmacy Services. With the completion of the cash-and-stock deal, Diplomat also announced that it has obtained $800 million in senior secured credit facilities.
Clavis Insight, an e-commerce specialist serving product manufacturers, is being acquired by Ascential plc, an international, business-to-business information company. Financial terms of the agreement weren’t disclosed.
Sens. Joe Manchin (D.) and Shelley Moore Capito (R.) of West Virgina helped Lynne Fruth, president of Fruth Pharmacy, launch the Bridge of Hope Fund, aimed at fighting the drug abuse epidemic.
The National Association of Chain Drug Stores is emphasizing the “Total” in its centerpiece Total Store Expo conference and trade show as it gets prospective attendees thinking about the 2018 event.
The pending $69 billion acquisition of Aetna by CVS could yield valuable lessons for others in the health care and drugstore sectors as they seek to forge stronger ties to consumers.
Chain drug store holiday sales bettered last year’s results, with total dollar volume rising more than 4%.
Walgreens Boots Alliance (WBA) plans to reduce its interest in Guangzhou Pharmaceuticals Corp., a pharmaceutical wholesale joint venture in China. WBA said Friday that, under the agreement, it will sell a 30% stake in Guangzhou Pharmaceuticals to Guangzhou Baiyunshan Pharmaceutical Holdings.
Susan Adzick has been promoted to senior vice president of sales and strategic relationships at McLane Co.
Timothy Crew, former chief executive officer of Cipla North America, is joining Lannett Co. as CEO. Plans call for Crew to take the CEO reins at effective Jan. 2, Lannett said. He also is slated to be appointed as a board director after the company’s 2018 annual shareholders meeting.
dubbed PharmAccord — that it said would enable governments to provide universal drug coverage to all Canadians, ensure
Albertsons Cos. is highlighting no-appointment flu shots at its pharmacies in response to reports of heightened influenza activity in parts of the country.
Merger partners Amneal Pharmaceuticals LLC and Impax Laboratories Inc. have tabbed Robert Stewart, executive vice president and chief operating officer of Allergan plc, to lead the combined company. Plans call for Stewart to join Amneal as president effective Jan. 25.
Campbell Soup Co. has agreed to acquire snack maker Snyder’s-Lance in a deal valued at about $4.9 billion. Campbell said the $50-per-share agreement will further its efforts to grow its snack product portfolio, notably better-for-you snacking options.
CVS Health’s Helena Foulkes has been tabbed as one of the keynote speakers at the National Retail Federation’s 2018 annual convention in Manhattan.
Bausch+Lomb has begun rolling out Vyzulta (latanoprostene bunod ophthalmic solution 0.024%) to U.S. pharmaceutical distributors. The Valeant Pharmaceuticals International subsidiary said Vyzulta is slated to become available to patients at pharmacies across the United States in the next few days.
The Hershey Co. aims to add more better-for-you options to its snack lineup with a $1.6 billion deal to buy Skinny Pop maker Amplify Snack Brands Inc.
